Lv11
10 积分 2022-07-05 加入
Discovery of Atirmociclib (PF-07220060): A Potent and Selective CDK4 Inhibitor
1小时前
待确认
The multifaceted phosphatidylinositol 5 phosphate 4-kinase proteins: molecular properties and biological functions
25天前
已完结
Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemia
1个月前
已完结
Preclinical Evaluation of the Efficacy of a Cyclin-dependent Kinase Inhibitor Ribociclib in Combination with Letrozole Against Patient-Derived Glioblastoma Cells
2个月前
已完结
Cardiovascular safety of CDK4/6 inhibitors in advance breast cancer: Assessing risks of QTc prolongation and thrombosis
3个月前
已完结
Combination of the MTA-Cooperative PRMT5 Inhibitor BMS-986504 and KRAS Inhibitors is an Effective Treatment Strategy for MTAP-Deleted KRAS-Mutant Pancreatic Cancer
3个月前
已完结
The curse of blood–brain barrier and blood–tumor barrier in malignant brain tumor treatment
4个月前
已完结
Gedatolisib in combination with palbociclib and endocrine therapy in women with hormone receptor-positive, HER2-negative advanced breast cancer: results from the dose expansion groups of an open-label, phase 1b study
4个月前
已完结
Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
4个月前
已完结
Dalpiciclib plus letrozole or anastrozole versus placebo plus letrozole or anastrozole as first-line treatment in patients with hormone receptor-positive, HER2-negative advanced breast cancer (DAWNA-2): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
4个月前
已完结
皖公网安备34019202002308
